These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 28810587)

  • 1. Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy.
    Yao K; Bian C; Zhao X
    Exp Ther Med; 2017 Aug; 14(2):1271-1276. PubMed ID: 28810587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome.
    Goudas VT; Dumesic DA
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and the polycystic ovary syndrome.
    Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective.
    Dumesic DA; Abbott DH; Sanchita S; Chazenbalk GD
    Curr Opin Endocr Metab Res; 2020 Jun; 12():41-48. PubMed ID: 32363240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
    González F
    Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes.
    Layacha SY; Biswas DA
    Cureus; 2023 Jan; 15(1):e33390. PubMed ID: 36751233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.
    Chaudhary H; Patel J; Jain NK; Joshi R
    J Ovarian Res; 2021 Sep; 14(1):125. PubMed ID: 34563259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Akopians AL; Madrigal VK; Ramirez E; Margolis DJ; Sarma MK; Thomas AM; Grogan TR; Haykal R; Schooler TA; Okeya BL; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4178-4188. PubMed ID: 27571186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
    Lin L; Du T; Huang J; Huang LL; Yang DZ
    Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome.
    Martens JW; Geller DH; Arlt W; Auchus RJ; Ossovskaya VS; Rodriguez H; Dunaif A; Miller WL
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4338-46. PubMed ID: 11095477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.